The individual variation in pharmacokinetics and pharmacodynamics of furosemide in young normal male subjects
- PMID: 6809473
- DOI: 10.1111/j.1365-2362.1982.tb01000.x
The individual variation in pharmacokinetics and pharmacodynamics of furosemide in young normal male subjects
Abstract
Following a 24 h control period in the ward 80 mg furosemide was injected intravenously to ten young healthy, male volunteers. The serum clearance of furosemide (Cls) was between 140 and 201 ml min-1 and on the average the renal clearance was 60% of Cls. During the initial 30 min period a maximum additional excretion rate of sodium of 3.3 mmol min-1 was reached at an excretion rate of 0.8 mg furosemide min-1. A marked initial drop in creatinine clearance (Clcr) was noted and Clcr(24 h) showed an average decrease of 12% after the drug administration. The serum concentration of potassium was decreased at 1 and 2 h after the injection and of sodium from 2 h and on. The concentration of albumin in serum increased by 3% (P less than 0.05) already after 5 min. After 2 h a maximum increase of 14% was reached. After 8 min diastolic blood pressure was increased by 13% (P less than 0.05), whereas systolic blood pressure reached a significant decrease gradually (7% after 3 h).
Similar articles
-
The influence of age on renal and extrarenal effects of frusemide.Br J Clin Pharmacol. 1984 Jul;18(1):65-74. doi: 10.1111/j.1365-2125.1984.tb05023.x. Br J Clin Pharmacol. 1984. PMID: 6743491 Free PMC article.
-
Fractional excretion of K, Na and Cl following furosemide infusion in healthy, young and very old people.Int Urol Nephrol. 2010 Mar;42(1):273-7. doi: 10.1007/s11255-009-9547-8. Epub 2009 Mar 10. Int Urol Nephrol. 2010. PMID: 19277890
-
The pharmacokinetics of frusemide are influenced by age.Br J Clin Pharmacol. 1983 Oct;16(4):391-7. doi: 10.1111/j.1365-2125.1983.tb02183.x. Br J Clin Pharmacol. 1983. PMID: 6626433 Free PMC article.
-
Furosemide kinetics and dynamics in patients with cirrhosis.Clin Pharmacol Ther. 1986 Jul;40(1):14-20. doi: 10.1038/clpt.1986.132. Clin Pharmacol Ther. 1986. PMID: 3720175
-
Furosemide pharmacokinetics and pharmacodynamics in health and disease--an update.J Pharmacokinet Biopharm. 1989 Feb;17(1):1-46. doi: 10.1007/BF01059086. J Pharmacokinet Biopharm. 1989. PMID: 2654356 Review.
Cited by
-
Responses to low dose intravenous perindoprilat infusion in salt deplete/salt replete normotensive volunteers.Br J Clin Pharmacol. 1994 Oct;38(4):329-34. doi: 10.1111/j.1365-2125.1994.tb04362.x. Br J Clin Pharmacol. 1994. PMID: 7833222 Free PMC article. Clinical Trial.
-
A quantitative method of evaluating the diuretic response to furosemide in rats.Pharm Res. 1988 Nov;5(11):694-8. doi: 10.1023/a:1015999626133. Pharm Res. 1988. PMID: 3247272
-
Furosemide disposition in patients on CAPD.Eur J Clin Pharmacol. 1995;48(5):385-90. doi: 10.1007/BF00194955. Eur J Clin Pharmacol. 1995. PMID: 8641327
-
Effects of the rate and composition of fluid replacement on the pharmacokinetics and pharmacodynamics of intravenous furosemide.J Pharmacokinet Biopharm. 1986 Oct;14(5):495-509. doi: 10.1007/BF01059657. J Pharmacokinet Biopharm. 1986. PMID: 3806372
-
Furosemide, fenclofenac, diclofenac, mefenamic acid and meclofenamic acid inhibit specific T3 binding in isolated rat hepatic nuclei.J Endocrinol Invest. 1988 May;11(5):355-60. doi: 10.1007/BF03349054. J Endocrinol Invest. 1988. PMID: 3183298
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous